Despite the considerable progress in disease gene discovery, we are far from uncovering the underlying cellular mechanisms of diseases since complex traits, even many Mendelian diseases, cannot be explained by simple genotype^phenotype relationships. More recently, an increasingly accepted view is that human diseases result from perturbations of cellular systems, especially molecular networks. Genes associated with the same or similar diseases commonly reside in the same neighborhood of molecular networks. Such observations have built the basis for a large collection of computational approaches to find previously unknown genes associated with certain diseases. The majority of the methods are based on protein interactome networks, with integration of other large-scale genomic data or disease phenotype information, to infer how likely it is that a gene is associated with a disease. Here, we review recent, state of the art, network-based methods used for prioritizing disease genes as well as unraveling the molecular basis of human diseases.
INTRODUCTION
Many ground-breaking discoveries of genes associated with human diseases and their molecular bases have dramatically increased our understanding of the development of diseases over the last decades [1] . Uncovering the underlying molecular basis of diseases has become incredibly valuable in the prevention, diagnosis and treatment of diseases. Despite the steady increase in discovering disease-associated genes, there is still a large fraction of diseases without a known molecular basis. Currently, there are over 1700 diseases with no known molecular basis curated in the OMIM (Online Mendelian Inheritance in Man) database as this review is being written. Even for those diseases for which there is a partial knowledge of a molecular basis, a large proportion of their associated genes are still not known. It has been reported that the genes established to be associated with diseases such as cancer and type 2 diabetes only represent a very small proportion of the incidences [2, 3] . Hence, the majority of disease genes still remain underneath the tip of the iceberg.
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do not follow the simple genotype-phenotype relationship hypothesis, but are rather the consequences of perturbations in the molecular networks induced by various factors such as genetic mutations, epigenetic changes and pathogens [6] . The efforts in unraveling the properties of disease genes in molecular networks have shown that genes associated with the same or similar diseases, tend to reside in the same neighborhood in these networks and form physical and/or functional modules [7] [8] [9] . These findings became the basis for the development of computational approaches for predicting and prioritizing candidate disease genes. In this review, we focus on state of the art approaches in this rapidly growing field that are built on interactome and protein-protein interaction (PPI) networks in particular.
MOLECULAR NETWORKS
Molecular networks, including PPI, metabolic, regulatory, genetic and co-expression networks, have been steadily constructed experimentally to characterize the physical and/or functional interactions between biomolecules (see [10, 11] for comprehensive reviews of these networks). Perturbations in these wiring diagrams may trigger particular phenotypes in both monogenic and polygenic diseases, including tumors ( Figure 1 ). Deciphering the properties of these networks will offer a much deeper understanding into complex genotype-phenotype relationships. Molecular networks can be subdivided into two categories: interactome networks (metabolic, PPI and gene regulatory networks) that represent physical or biochemical interactions between macromolecules, and functional networks (transcription profiling, phenotypic profiling and genetic interaction networks) that display functional relationships or similarities between genes and gene products [11] . These networks are commonly displayed as a graph with nodes as molecules and directed or undirected edges as links between them [12] (Box 1 for basic graphic concepts of networks). PPI networks usually have undirected edges, representing the physical interactions between the proteins (i.e. nodes). On Figure 1 : Perturbations in molecular networks disrupt biological pathways and result in human diseases. Mutations in a node (white) cause different types of perturbations in molecular networks with directly affected neighbors shown in black. Disease A is triggered as the result of an edge removal, and disease B is developed due to the node removal. The two diseases are not necessary the same, but may share similarity in phenotypes.
the contrary, gene regulatory networks are constructed with the nodes connected by directed edges representing physical binding of one node (transcription factor) to the other nodes (DNA regulatory elements). In metabolic networks, the nodes are biochemical metabolites and the edges, either directed or undirected, represent reactions or enzymes catalyzing the reactions to convert one node into another. Functional networks of transcription profiling, phenotypic profiling and genetic interaction, all have nodes representing genes, but edges representing highly correlated co-expression, highly correlated phenotypic profiles and known genetic interactions, respectively. The current status as well as approaches for constructing these networks can be found in two recent comprehensive reviews [10, 11] .
Many proteins carry out their functions through interacting with other proteins. Two main highthroughput technologies have been advanced and are successful in producing a large number of PPIs in humans: (i) a high-throughput yeast two-hybrid (Y2H) system has been developed to systematically screen for direct binary interactions between protein pairs [13] [14] [15] and (ii) high-throughput affinity purification (AP) followed by mass spectrometry (MS) approaches have been employed to identify protein complexes in humans [16, 17] . Significant efforts have also been made to search through the literature and curate the interactions that have been reported by small-scale experiments, as was done in a large number of databases such as Human Protein Reference Database (HPRD), Molecular Interaction database (MINT), Biological General Repository for Interaction data sets (BioGRID), Biomolecular Interaction Network Database (BIND) and IntAct [18] [19] [20] [21] [22] . Despite the fact that errors and biases are still present in this incomplete human PPI network [23] , the nonstop exertion in constructing high-coverage and high-quality PPI networks has made the computational prediction of disease genes possible. It should be noted that, although in this review, we focus specifically on decoding PPI networks for discovery of disease genes, analogous principles can be applied to the other types of networks mentioned above.
THE PROPERTIES OF DISEASE GENES IN PPI NETWORKS
Most molecular networks are scale-free such that the distribution of node connectivity (number of neighbors) follows a power law rather than a Poisson distribution. In such scale-free networks, the majority of nodes have few links while other nodes, so called hubs, have a much higher degree of linkages. In model organisms, hub proteins have been reported as essential and more abundant, and they generally display a greater diversity of phenotypes in knockouts when compared to nonhub proteins [24] [25] [26] [27] [28] . These findings lead to the question of whether or not disease-associated genes in humans tend to encode hubs in cellular networks. The analysis of differentially expressed genes in cancer suggested that up-regulated genes in lung squamous cancer tissues have significantly higher connectivity in the PPI network [29] . A similar conclusion was drawn by Jonsson and Bates [30] that cancer-related proteins have about twice the interaction partners when compared with proteins unrelated to cancer. However, these observations may be the result of a bias, in that cancer proteins are often much better studied. Goh et al. [8] showed that disease gene products displayed more of a tendency to encode hubs in the PPI network than nondisease gene products. However, further investigation demonstrated that only essential disease genes were associated with hubs and were widely expressed, while nonessential disease genes did not demonstrate these characteristics [8, 9] . Another observation is that network neighbors of disease genes tend to be involved in the same or similar diseases. Genes causing similar disease phenotypes are often functionally related and form a biological module such as a protein complex or pathway [7] . Goh et al. [8] showed that genes associated with the same disorder have significantly higher gene ontology (GO) homogeneity than random expectation as well as an increased tendency to be co-expressed. It has been shown that genes causing the same phenotype tend to form topological clusters [9] . These distinct features of disease genes as revealed by interactome and functional networks can be adopted to identify functionally similar genes in addition to uncharacterized disease genes.
DISEASE GENE PREDICTION Proximity of proteins in the PPI network
Current approaches for disease gene prioritization mostly rely on the proximity of candidate genes to known disease genes within interactome networks using different scoring strategies. The underlying assumption is 'guilt-by-association', in that, genes that are physically or functionally close to each other tend to be involved in the same biological pathways and have similar effects on phenotypes [31, 32] . Hence, a key step is to measure the distance between candidate genes and known disease genes in the PPI network, for which an increasing number of approaches have been developed [33, 34] . Here, we focus on three main categories: local distance measurements, global distance measurements and other graphic clustering methods to measure pair-wise protein closeness in a network for prioritizing candidate genes ( Table 1) .
The most straightforward approach is to assess whether two proteins are connected directly in a network, so called direct neighbor counting. The count for any protein pair is 1 if the two proteins are directly connected by an edge, with count of 0 otherwise (see Table 1 ). The more disease genes that a candidate gene is directly connected to, the more probable it is that the candidate is associated with the same disease. Oti et al. [35] predicted disease-causing genes in known disease loci by counting the number of known causative genes in their direct network neighbors (Table 2) . They achieved an Table 1 : Approaches for measuring proximity of elements in PPI networks
The countN uv for protein pair u and v is 1 if they are directly connected by an edge E uv , and is 0 otherwise. [35, 38, 39, 43, 45, 50, 51, 55] Shortest path length
The distance D uv between protein u and v is the shortest path length L uv . L 0 uv is the length of any possible path connecting protein u and v. [37, 44, 55, 77] Diffusion kernel K ¼ e
ÀL
The diffusion kernel K of the graph is the function of Laplacian L, the difference of the degree matrix and the adjacency matrix, with parameter as the control of diffusion magnitude.
[38]
Random walk with restart
The random walk with restart is an iterative walker's transition from the current node to a random neighbor with probability r to restart the walk at the source node. W is the adjacency matrix of the graph and P t is the probability vector being at the nodes at iteration t.
[38, 39, 57] Propagation flow
is the prioritization function representing the relevance of proteins in the network to the seed nodes at iteration t. Each node propagates information received from the previous iteration to its neighbors. Y is the prior information, is the parameter controling the importance of the prior information and W 0 is the normalized weight matrix.
[58] Shortest path length Find smallest set of genes that cover the disease related genes using the Maximum expectation gene cover algorithm.
(continued) approximately 10-fold enrichment by comparing their candidates to a random selection of candidate genes at the same locus. Since two proteins can be involved in the same biological pathway without a physical interaction, a number of researchers quantified the closeness of proteins in PPI networks using the shortest path length between them [36, 37] . Krauthammer et al. [36] assigned known disease genes as seed nodes and computed the shortest path length between these and other nodes in the network. A node that has close proximity to multiple seed nodes receives a higher score as a candidate disease gene. The authors evaluated the method in predicting genes associated with Alzheimer's disease and showed that the genes predicted by their approach agreed with the manually curated candidates.
Neither of the above two local distance measurements captures the overall interaction network structure. As demonstrated by Kohler et al. [38] , the closeness of two proteins cannot be fully represented by their shortest path length. Different network structures surrounding two proteins (eg. two proteins are connected by a hub, or by a protein with a low degree, or through more than one shortest path) imply different degrees of closeness between them. Global distance measurements can catch that difference by allowing equal probability of one protein to diffuse along the links of the PPI network. They tested 110 disease families containing 783 genes in prioritizing disease genes using local distance measures (direct neighborhood and shortest path length) and global similarity measures (diffusion kernel and random walk with restart). The random walk with restart method achieved an area under Receiver Operating Characteristic curve of up to 98% on simulated linkage intervals containing 100 genes, the best performance among all of the tested methods. The other global similarity-based diffusion kernel approach is also superior to the local distance measurement methods, although its performance is slightly poorer than random walk with restart. Navlakha and Kingsford [39] compared the performance of disease gene prediction using different distance measurement methods including network neighbors, random walk with restart, propagation flow, unsupervised graph partitioning, Markov clustering and semi-supervised graph partitioning. They obtained unweighted PPI networks from HPRD and the Online Predicted Human Interaction Database (OPHID), grouped diseases from the OMIM morbid-map file based on their names and extracted loci for the associated genes from UniProt [40, 41] . They reported that random walk with restart gave the best performance in terms of precision and recall, while both random walk and propagation flow are superior to clustering and neighborhood methods. They showed that each of these methods made novel predictions that were not uncovered by another, and that only a few incorrect predictions were made using the combined methods. Hence a consensus method combining all 13 closeness measurements was proposed and selected in tandem for the ensemble of decision trees using a random forest classifier. It was demonstrated that the consensus method gave the best performance due to its ability to capture different topological properties of the PPI network.
Integration of large-scale genomic data
Many integrative approaches have been proposed for uncovering disease genes based on the assumptions that the disease genes would also share common features in gene ontology annotations, gene expression, protein sequences and domains and are likely involved in similar biological pathways and functional pathways [8] . While better prediction performance can often be achieved by integrating multiple data sources [42] , the question lies in how to incorporate these heterogeneous data together for learning.
Endeavour, a prioritization algorithm through genomic data fusion, integrated more than 10 features and ranked the candidate genes based on their similarity to known disease genes for each of these features [43] . The authors first collected information for known disease genes by considering functional annotations, microarray expression, EST expression, literature, protein domains, PPIs, pathway membership, cis-regulatory modules, transcriptional motifs, sequence similarity and other potential data sources to be added by users. Then, candidate genes of interest were ranked based on their similarity to known disease genes in each of these features. A global ranking to prioritize candidate genes was generated by combining the ranks of individual features using order statistics. Not surprisingly, the performance based on all the data sources was shown to be much better than using partial data sources. The correct gene, in the validation of 703 disease and pathway genes, was ranked 10th among 100 candidate genes on average.
Functionally linked networks were proposed for prioritizing candidate genes by consolidating information from various data sources using a Bayesian classifier [44, 45] . Prioritizer first constructed four types of functional networks by combining different types of data sources such as gene ontology, gene expression and PPI [44] . Artificial susceptibility loci containing 50-150 genes, in steps of 50, surrounding the known disease genes were generated. The closeness in the functional network of a candidate gene in one susceptible locus to genes residing in another locus was assessed and assigned a higher score for a shorter distance. A permutation test was performed to generate P-values for prioritizing candidate genes. Prioritizer reached 2.8-fold enrichment compared to random selection.
While at least two susceptible loci are desired in Prioritizer, Linghu et al. [45] performed genomewide prioritization by constructing an evidenceweighted functional linkage network of 21 657 genes based on 16 data sources. Pair-wise functional associations among genes in each feature were integrated into a single functional linkage network, weighted by overall functional associations, using a naïve Bayes classifier. For any given disease, scores of candidate genes for prioritization were assigned based on the sum of the weights of the network links to known disease genes. The algorithm was tested on prioritizing disease genes for 110 diseases using gene-centric and disease-centric assessments and showed outstanding performance. By testing the monogenic, polygenic and cancer disease families grouped by Kohler etal. [38] based on similar phenotypes, the authors observed the best performance for monogenic disease families. The fact that the performance using the integrated functional network (62% success rate) is better than using the PPI network alone (40% success rate) confirms the importance of data integration for prioritizing candidate disease genes.
Integration of phenotypic information
It has been shown that diseases with similar phenotypes often share either a common set of underlying genes or functionally related genes [46] . This observation was used to construct disease networks in which two diseases are connected, if they share at least one common gene [8] . A number of different approaches have been developed to score similarities between diseases. Rzhetsky et al. performed a study on 1.5 million patient records and 161 disorders using a statistical model and found that disease phenotypes form a highly connected network with strong pair-wise correlations [47] . A similar disease phenotype network was constructed by connecting diseases based on their co-occurrences in a large number of patients [48] . A couple of text mining techniques were used to map OMIM diseases to different standard vocabularies, Medical Subject Headings (MeSH) or the Unified Medical Language System (UMLS), to score pair-wise similarities among the disease records [49, 50] . Other phenotype similarity measures were also reported based on reciprocal references or the constructed human phenotype ontology [51, 52] . The scores from the disease phenotype network have been indicated to be positively correlated with several measures of gene functions [49] . A particular example where interactome and phenotype networks can reinforce each other was shown for spinocerebellar ataxia. Lim et al. [53] and Kahle et al. [54] used Medicare patient records to determine if any disease associated with proteins in the ataxia interactome also co-occurs with hereditary ataxia. One of the diseases that comorbid with ataxia was macular degeneration (MD). The ataxia interactome is significantly (P ¼ 7.37e-5) enriched with proteins that interact with known MD-causing proteins, forming a MD subnetwork.
Based on the assumption that phenotypically overlapping diseases share functionally similar underlying genes, it is desirable to incorporate such phenotypic similarity profiles to candidate gene prioritization. Several studies reported that the integration of disease phenotype networks and PPI networks outperform other approaches in the prioritization task [50, 51, [55] [56] [57] [58] . Wu et al. [55] used a simple linear regression method called CIPHER (Correlating protein Interaction network and PHEnotype network to pRedict disease genes) to model the correlation between phenotype similarity profile and gene closeness profile in the PPI network. The underlying assumption of the algorithm is that the phenotype similarity between two diseases can be explained by the proximity of the disease genes in the PPI network. The authors obtained the phenotype similarity data from van Driel et al.'s [49] text mining results and generated the network of 72 431 unique pair-wise binary interactions between 14 433 human genes by combining manually curated PPIs from HPRD, BIND, MINT and predicted PPIs from OPHID. The Pearson correlation coefficient of the disease similarity profile for disease p and the gene closeness profile for gene g is calculated using the proposed linear regression model and recorded as a concordance score to represent the association of gene g and disease p. They showed that their predictions are reliable in prioritizing candidate genes in both linkage intervals and the entire genome, and more importantly, can potentially be applied to gene discovery for diseases without any known associated genes. Further, they demonstrated that the performance of CIPHER is comparable to that of Endeavor, an integrative approach that employed more than 10 large-scale genomic data as discussed above [43] . Interestingly, the authors showed that the direct neighbor approach for measuring the proximity of genes in the PPI network outperforms the shortest path length approach. However, as the authors addressed, the direct neighbor approach failed to assign ranks to many novel susceptibility genes in a breast cancer case study.
A similar approach was developed by Vanunu etal. [58] who adopted the same phenotype similarity metric computed by van Driel et al. [49] . They calculated the association between a query disease d and a protein p with a known disease gene for another disease d 0 using a logistic function dependent on the phenotype similarity between d and d 0 . This disease protein association was then used as prior knowledge in the constructed prioritization function, representing the relevance of protein p with disease d, to iteratively smooth itself over the network using the network propagation formula (Table 1) . This algorithm, named PRINCE (PRIoritizatioN and Complex Elucidation), was demonstrated to successfully predict not only genes, but also protein complexes associated with a disease. In addition to the utilization of weighted (PRINCE) and unweighted (CIPHER) PPI networks, the major difference for PRINCE and CIPHER is that PRINCE utilized a global network propagation approach, while CIPHER only used local distance measure approaches [55] . Not surprisingly, PRINCE showed superior performance over CIPHER in prioritizing genes for 1369 diseases with a known causal gene by $10% in ranking the real disease gene as the top-scoring one. The authors also showed that their approach outperforms the random walk with restart method [38] . Interestingly, the opposite conclusion was drawn by Navlakha and Kingsford [39] as discussed earlier. This discrepancy indicates the performance difference between random walk with restart and propagation flow might be marginal and fluctuate with different data sources and network setup.
Li and Patra constructed a heterogeneous network by integrating the PPI network and phenotype network based on disease-gene relationships in the OMIM [57] . The authors developed a new algorithm by extending the random walk with restart algorithm from only the PPI network to the entire heterogeneous network. The random walker is no longer restricted in the gene network but is also allowed to jump to the phenotype network. This Random Walk with Restart on Heterogeneous network (RWRH) algorithm prioritizes the genes and phenotypes simultaneously. In comparison with CIPHER, it showed that RWRH was superior in prioritizing disease genes under three different circumstances: known disease genes and genetic loci, known disease genes but no known genetic loci and no known disease genes or loci [55] . Further, RWRH was demonstrated to outperform random walk with restart with Area Under Curve (AUC) values of 0.96 and 0.92 respectively in prioritizing disease genes [38] . The inclusion of a phenotype network and the improved algorithm in smoothing both molecular and phenotype networks greatly enhanced the disease gene prioritization performance.
Other biological information has also been combined into the gene-phenotype heterogeneous network to aid in finding disease genes. Based on the hypothesis that disease genes and their interaction partners should have more deleterious single nucleotide polymorphisms (SNPs) than other genes, Care et al. [51] predicted deleterious SNPs using the random forest classifier and incorporated this information along with the PPI and phenotype networks for predicting disease genes using the same classifier. The predicted deleterious SNPs were higher in disease genes, and the inclusion of such information increased the average recall by 4% based on all PPI data and 1% based on PPI from high-throughput experiments.
Construction of disease modules
In addition to the global candidate gene prioritization algorithms, significant efforts have been made towards the discovery of disease genes for individual diseases by constructing disease modules [10] . Network components in such topological modules are believed to be functionally related and the breakdown of one module will result in a particular disease. The information for known disease genes are collected and used to construct disease modules or subnetworks, in which members would share similar functions, expression patterns or metabolic pathways. The concept has been employed in the study of various diseases including, but not limited to, different types of cancers, type 2 diabetes, obesity, asthma, neurological diseases and so on [59] [60] [61] [62] [63] . This disease module approach, especially for not well-studied diseases, often requires major experimental efforts to identify interactions for constructing the module of interest.
Liu et al. [62] used a network-based approach and identified an insulin signaling module as well as a network of nuclear receptors that play significant roles in type 2 diabetes. Together with a subnetwork of PPIs, the authors suggested the underlying biological processes for this disorder. In a study of obesity, tissue-tissue co-expression networks between genes in the hypothalamus, liver or adipose tissue were constructed and enabled the identification of disease-specific genes [61] . The study showed that many genes included in the subnetworks were involved in obesity-related biological functions such as circadian rhythm, energy balance, stress response or immune response.
A slightly different approach was developed to prioritize disease-specific genes by constructing disease-and condition-specific subnetworks [64] . Disease-specific genes, such as differentially expressed genes identified under disease conditions, were mapped to global PPI network. The shortest path subnetwork was then built by including only the nodes in the shortest path connecting the disease-specific genes. Each node in this subnetwork was evaluated and assigned a topological score by comparing the number of shortest paths of node pairs traversing it in this subnetwork to the number of shortest paths through it in the global network. This topological scoring algorithm was verified using gene expression data from psoriasis patients and was able to identify novel targets of psoriasis.
FUTURE PERSPECTIVES
In summary, enormous progress has been made towards decoding the molecular networks and predicting novel genes associated with diseases based on these networks (Figure 2 ). Various distance measurements of two gene products in a network were explored and the global distance methods were demonstrated to be superior to local distance measurements. In the postgenomic era, with the deluge of large-scale genomic data, integrative approaches have also been developed to combine these types of data for prioritizing candidate genes for human diseases. However, these integrative methods tend to use overly simple network distance measurements. As shown by several groups, the inclusion of phenotype similarity networks significantly increases the performance in prioritizing disease genes. In certain cases, approaches combining phenotype networks alone even outperform those combining other multiple types of data. The utilization of phenotype similarities can potentially be used for ab initio predictions where no known genes are identified for certain diseases. Nevertheless, caution needs to be taken for obtaining such similarity scores between diseases based on text mining as biases and circularity can be induced [65] , which will lead to an overestimation of the performance.
Since a direct comparison of different methods is often difficult due to the unavailability of some algorithms and the usage of different data sources, self-reported performance such as fold enrichment was sometimes used for comparison. One major caveat of such comparisons is that the differences in performance might be due to differences in the input data sets rather than the algorithms themselves. As shown earlier, different input interaction data sets can lead to very different performances [38] . In most prioritization methods, all known disease genes were considered equally. It might be useful to develop new algorithms to assign different weights to known disease genes in finding novel ones. Furthermore, distinct effects of node removal (complete loss of gene products) and edgetic perturbations (edge-specific interruptions) to the molecular networks should be recognized to confer different functional consequences [66] . The incorporation of such distinct perturbations should significantly improve the specificity in prioritizing candidate genes. Although not discussed in this review, other nonnetwork-based methods for prioritizing disease genes should also be appreciated [67] [68] [69] .
Although huge efforts have been made toward finding PPIs in human, we still have an incomplete map of the network due to the high complexity of networks. Common problems for predicting disease genes based on networks are the existence of noise (false positives) in curated PPI databases and gene expression profiling experiments in addition to the bias towards well-studied disease genes [23, 70] . High quality molecular networks are desired to increase the prediction power and are realizable with advances in high-throughput methods [26] . While efforts have been made mostly on human molecular networks, it is worth noticing that an increasing number of protein interaction networks are under construction for microbial pathogens [71] [72] [73] [74] [75] [76] . Combining viral protein networks and human protein networks, so called 'virhostome', might unravel key mechanisms of pathogen infection since virushost interactions are mostly physical interactions [11] .
To conclude, the integration of steadily growing cellular interactomes including PPI networks, regulatory networks, metabolic networks and virus-host networks are crucial for understanding the mechanisms of human diseases and predicting novel candidate genes associated with diseases.
Key Points
Human diseases are the consequences of disruption in molecular networks. Genes associated with the same or similar diseases tend to reside in the same neighborhood of molecular networks. Prioritizing schemes for finding disease-associated genes. Candidate genes (within linkage intervals or genome wide) and known disease genes are mapped to interactome networks. The distance between candidate genes and known disease genes in interactome networks, functional networks or gene-phenotype networks are measured using different methods to score and rank candidate genes.
Network-based computational approaches have been developed to find novel disease genes and prioritize candidate genes. Global distance measurements between candidate genes and known disease genes in networks outperform local distance measurement approaches in prioritizing candidate genes. The integration of large-scale genomic data or phenotypic information with networks greatly increases the prediction performance.
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